Loading...
Derniers dépôts
-
Charlotte Rigaud, Léa Guerrini-Rousseau, Véronique Minard-Colin, Laurence Brugieres, Victoria J. Forster, et al.. Comprehensive analysis of constitutional mismatch repair deficiency-associated non-Hodgkin lymphomas in a global cohort. Pediatric Blood and Cancer, 2024, ⟨10.1002/pbc.31302⟩. ⟨hal-04724649⟩
-
María-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi-Yan Han, Céline Chauvin, Julien Masliah-Planchon, et al.. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups. Nature Communications, 2023, 14 (1), pp.6669. ⟨10.1038/s41467-023-42371-7⟩. ⟨hal-04295076⟩
-
Sue Cheeseman, Bethany Levick, Will Sopwith, Hayley Fenton, Eun Ji Nam, et al.. Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes. Frontiers in Oncology, 2023, 13, pp.1114435. ⟨10.3389/fonc.2023.1114435⟩. ⟨hal-04756405⟩
-
Bujamin Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, Alexandra Helleux, Marc Rippinger, et al.. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nature Communications, 2023, 14 (1), pp.3034. ⟨10.1038/s41467-023-38472-y⟩. ⟨hal-04755616⟩